Crystalloid deposits in the kidney

Nephrology

Volumn 10, Issue 1, 2005, Pages 81-83

  Keller, Lisa Suzanne ^a   Faull, Randall James ^a   Smith, Peter ^b   Swift, Jeffrey ^b   Bannister, Kym Malcolm ^a   Otto, Sophie ^b   Peh, Chen Au ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Crystalloid; Multiple myeloma; Nephropathy

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CRYSTALLOID; CRYSTALLOID NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY BIOPSY; KIDNEY DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE MYELOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RARE DISEASE;

CRYSTALLIZATION; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 14844328094     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00290.x     Document Type: Article

References (16)

1. Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J. Perspectives in multiple myeloma: Survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q. J. Med. 1991; 79: 517-25.
2. Kapadia SB. Multiple myeloma: A clinicopathologic study of 62 consecutively autopsied cases. Medicine 1980; 59: 380-92.
3. Carstens PHB, Woo D. Crystalline glomerular inclusions in multiple myeloma. Am. J. Kidney Dis. 1989; 14: 56-60.
4. Lajoie G, Leung R, Bargman JM. Clinical, biochemical and pathological features in a patient with plasma cell dyscrasia and fanconi syndrome. Ultrastruct. Pathol. 2000; 24: 221-6.
5. Gu X, Barrios R, Cartwright J, Font RL, Truong L, Herrera GA. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: The role of immunoelectron microscopy. Hum. Pathol. 2003; 34: 270-7.
6. Neumann V. Multiple plasma-cell myeloma with crystalline deposits in the tumor cells and in the kidneys. J. Path. Bacteriol. 1949; 61: 165-9.
7. Jenkins RE, Calonje E, Fawcett H, Greaves MW, Wilson-Jones E. Cutaneous crystalline deposits in myeloma. Arch. Dermatol. 1994; 130: 484-8.
8. Mullen B, Chalvardjian A. Crystalline tissue deposits in a case of multiple myeloma. Arch. Pathol. Lab. Med. 1981; 105: 94-7.
9. Sethi S, Cuiffo BP, Pinkus CS, Rennke HG. Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am. J. Kidney Dis. 2002; 39: 183-8.
10. Ronco PM, Aucouturier P, Mougenot B. Monoclonal gammopathies, multiple myeloma, amyloidosis, and related disorders. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract, Vol. 3, 7th edn. Philadelphia: Lippincott Williams and Wilkins, 2001; 2205-53.
11. Hill GS, Morel-Maroger L, Mery JP, Brouet JC, Mignon F. Renal lesions in multiple myeloma: Their relationship to associated protein abnormalities. Am. J. Kidney Dis. 1983; 2: 423-38.
12. Lebeau A, Zeindl-Eberhardt E, Muller EC, Muller-Hocker J, Jungblut PR, Emmerich B, Lohrs U. Generalised crystal-storing histiocytosis associated with monoclonal gammopathy: Molecular analysis of a disorder with rapid clinical course and review of the literature. Blood 2002; 100: 1817-27.
13. Aucouturier P, Bauwens M, Khamlichi AA et al. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J. Immunol. 1993; 150: 3561-8.
14. Decourt C, Rocca A, Bridoux F et al. Mutational analysis in murine models for myeloma-associated Fanconi's syndrome or cast myeloma nephroparhy. Blood 1999; 94: 3559-66.
15. Leboulleux M, Lelongt B, Mougenor B et al. Protease resistance and binding of Ig light chains in meloma-associated tubulopathies. Kidney Int. 1995; 48: 72-9.
16. Kanno Y, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H. Crystal nephropathy: A variant form of myeloma kidney - a case report and review of the literature. Clin. Nephrol. 2001; 56: 398-401.